The impact of childhood cancer on parents' socio-economic situation-A systematic review. by Roser, K. et al.
This is a repository copy of The impact of childhood cancer on parents' socio-economic 
situation-A systematic review..
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/146633/
Version: Accepted Version
Article:
Roser, K. orcid.org/0000-0001-5253-3333, Erdmann, F. orcid.org/0000-0002-9982-3300, 
Michel, G. orcid.org/0000-0002-9589-0928 et al. (2 more authors) (2019) The impact of 
childhood cancer on parents' socio-economic situation-A systematic review. 
Psycho-Oncology. ISSN 1057-9249 
https://doi.org/10.1002/pon.5088
This is the peer reviewed version of the following article: Roser, K, Erdmann, F, Michel, G, 
Winther, JF, Mader, L. The impact of childhood cancer on parents' socio economic ‐
situation—A systematic review. Psycho Oncology. 2019, which has been published in final ‐
form at https://doi.org/10.1002/pon.5088. This article may be used for non-commercial 
purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived 
Versions.
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
 This article has been accepted for publication and undergone full peer review but has not been 
through the copyediting, typesetting, pagination and proofreading process which may lead to 
differences between this version and the Version of Record. Please cite this article as doi: 
10.1002/pon.5088 
 
This article is protected by copyright. All rights reserved. 
 
Roser Katharina (Orcid ID: 0000-0001-5253-3333) 
Michel Gisela (Orcid ID: 0000-0002-9589-0928) 
Mader Luzius (Orcid ID: 0000-0001-5613-4356) 
 
 
The impact of childhood cancer on parents´ socio-economic 
situation - a systematic review 
Katharina Roser1, Friederike Erdmann2, Gisela Michel1, Jeanette Falck Winther2,3, 
Luzius Mader2 
 
1Department of Health Sciences and Health Policy, University of Lucerne, Switzerland; 
2Childhood Cancer Research Group, Danish Cancer Society Research Center, 
Denmark; 
3Department of Clinical Medicine, Faculty of Health, Aarhus University, Denmark. 
 
Short title: 
Impact of childhood cancer on parents´ socio-economic situation 
 
Key words: 
Childhood cancer; father; mother; oncology; parents; socio-economic situation; 
employment; income; systematic review 
 
Corresponding author: 
  
This article is protected by copyright. All rights reserved. 
Luzius Mader, Childhood Cancer Research Group, Danish Cancer Society Research 
Center, Strandboulevarden 49, 2100 København Ø, Denmark. 
Phone: +4535257628, email: luma@cancer.dk 
 
Abstract 
Objective: Taking care of children diagnosed with cancer may have considerable 
consequences on parents´ socio-economic situation. Our systematic review aimed to 
evaluate and synthesize the evidence on the impact of childhood cancer on parents´ 
socio-economic situation. 
Methods: Systematic literature searches for articles published between January 2000 
and January 2019 were performed in PubMed, Scopus, and PsycINFO. Findings of 
eligible articles were narratively synthesized and quality appraised. 
Results: Our systematic review included 35 eligible articles. Childhood cancer had a 
substantial impact on parents´ socio-economic situation across all studies. This impact 
varied largely by geographical region. We observed a high prevalence of disruptions 
in parental employment such as job quitting or job loss, particularly among mothers. 
The associated income losses further contributed to families´ perceived financial 
burden in addition to increased cancer-related expenses. Adverse socio-economic 
consequences were most pronounced shortly after diagnosis, however, persisted into 
early survivorship for certain groups of parents. We identified families of children 
diagnosed with haematological cancers, younger age at diagnosis, and lower parental 
socio-economic position to be at particular risk for adverse socio-economic 
consequences. 
Conclusions: Following the child´s cancer diagnosis, parents experience a broad 
range of adverse socio-economic consequences. Further effort is needed to 
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systematically implement an assessment of financial hardship in paediatric oncology 
together with appropriate support services along the cancer trajectory. 
 
Background 
Childhood cancer is a devastating experience for the whole family system with few 
life events being as far outside a family´s routine1. This is particularly challenging for 
the parents who are confronted with the potential fatality of the disease and conflicting 
caregiving, emotional, and practical demands2. The FKLOG¶VDFXWHWUHDWPHQW requires 
frequent hospitalizations, invasive procedures, and depending on the cancer type, a 
combination of surgery, chemotherapy, and radiotherapy3. Parents are often involved 
by providing and monitoring treatment or managing treatment-related symptoms, 
particularly in the outpatient setting4,5. Due to the increased risk for late effects after 
treatment6, long-term follow-up care is recommended for childhood cancer survivors7. 
Even years after treatment, many parents remain actively involved in the child´s 
medical care8,9. 
The management of the child´s disease alongside everyday responsibilities is 
highly challenging for the parents. Previous research indicates that parents of children 
with cancer experience substantial work and income disruptions during the child´s 
treatment10. Moreover, many parents are confronted with medical and non-medical 
expenditures11-16. Direct costs of childhood cancer have been evaluated in two reviews 
concluding that substantial financial toxicity may occur in paediatric oncology10,17. 
However, a comprehensive assessment of parents´ socio-economic situation also 
including aspects related to financial assistance is currently lacking. It further remains 
unclear whether the socio-economic situation of mothers and fathers is differentially 
affected due to different parenting roles and tasks18. Moreover, evidence on temporal 
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patterns after the diagnosis and socio-demographic or cancer-related determinants of 
adverse socio-economic consequences is lacking. There may be groups of parents 
that particularly struggle with their professional life during treatment or to re-establish 
and compensate work-related disruptions after the child´s cure. Identifying parents 
who are at particular risk of adverse socio-economic consequences is crucial to 
provide targeted supportive services along the cancer trajectory to reduce these 
inequities from an individual and societal perspective. 
The objective of this systematic review was to critically evaluate and synthesize 
the evidence on the impact of childhood cancer on parents´ socio-economic situation. 
Specifically, we aimed to address the following research questions: 
i. What are the consequences of childhood cancer for the parents´ socio-
economic situation regarding employment, income, financial situation, and 
financial assistance? 
ii. Are there differences in the consequences between mothers and fathers of 
children with cancer? 
iii. Are there temporal patterns in the consequences after the child´s cancer 
diagnosis? 
iv. What are the main socio-demographic and cancer-related characteristics 
associated with adverse socio-economic consequences?  
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Methods 
Our systematic review complies with the PRISMA statement regarding the 
reporting of systematic reviews and meta-analyses19. A review protocol was registered 
in PROSPERO (number: CRD42018096121). 
Search strategy 
Our literature search was conducted on 23 March 2018 and included articles 
published in peer-reviewed journals after 1 January 2000 that were indexed in the 
databases PubMed, Scopus, and PsycINFO. This time frame was chosen to account 
for improvements in cancer treatment protocols over time. The search was updated 
on 11 January 2019. Our search included four individual blocks with search terms 
referring to socio-economic situation, parents, childhood, and cancer (Supplementary 
figure 1). In PubMed we additionally performed searches using medical subject 
headings (MeSH). We hand-searched reference lists of included studies to identify 
other relevant articles. 
Study selection 
To select eligible articles, we hierarchically applied the following inclusion criteria: 
sample size >20, quantitative methodology, parents of children with cancer as main 
study population, child´s age at cancer diagnosis <20 years, parents´ socio-economic 
situation as primary outcome. Editorials, commentaries, conference abstracts, and 
original articles without English full-text were excluded. We excluded studies solely 
focusing on costs or expenses as the respective literature has been previously 
reviewed10,17. Two reviewers (LM, KR) independently assessed eligibility by first 
screening titles and abstracts followed by the full-texts of remaining studies. 
Discrepancies between reviewers were resolved by consensus or consulting a third 
reviewer (FE). 
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Data extraction 
We extracted first author, publication year, country, study design, sample size(s), 
and response rate(s). For parents of children with cancer and comparison parents (if 
applicable) we extracted data on sex, age at study, and other available socio-
demographic characteristics. Socio-economic consequences of childhood cancer 
regarding employment, income, financial situation (financial burden, material 
hardship), and financial assistance (governmental, non-governmental) were extracted. 
We further extracted the following cancer-related characteristics of the child: 
diagnosis, treatment, diagnostic period, age at diagnosis, follow-up period, and 
treatment phase (categorized into survivors [completed treatment], patients [active 
treatment], deceased [death due to cancer]). 
Quality assessment 
Study quality was independently assessed by two reviewers (LM, FE) using the 
Newcastle-Ottawa Quality Assessment Scale (NOS)20 as recently used in a review 
addressing childhood cancer survivors21 (Supplementary table 1). NOS evaluates the 
quality of non-randomised studies with a star rating system (maximum 9 stars) based 
on three criteria: selection (4 items, max. 1 star/item), comparability (1 item, max. 2 
stars), and outcome (3 items, max. 1 star/item). The criterion selection refers to the 
representativeness of the study population(s) (parents of children with cancer, 
comparison parents) and the exposure ascertainment (childhood cancer diagnosis). 
According to the NOS´ manual20, we defined education as the most important factor 
to adjust for in a comparison between study populations for the criterion comparability. 
An additional star was appointed to studies controlling for sex, age, or year of outcome 
assessment. The criterion outcome refers to type of outcome assessment, length of 
follow-up, and adequacy of follow-up. A follow-up rate of >70% was considered 
unlikely to introduce bias22. 
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Data synthesis 
Findings related to parents´ socio-economic situation were narratively 
synthesized. A priori, we decided not to follow a meta-analytic approach due to 
expected heterogeneity related to study design, study period, and outcome definition 
between studies and differences in socio-economic context across geographical 
regions23. The narrative synthesis focused on the socio-economic consequences 
regarding employment, income, financial situation, and financial assistance, 
differences between mothers and fathers, temporal patterns after diagnosis, and 
characteristics associated with adverse socio-economic consequences. We further 
evaluated how the quality of included studies may have affected our synthesis. 
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Results 
Literature search and study characteristics 
We identified 3359 articles through literature searches and included 35 articles24-
58
, reporting on 29 individual studies (Figure 1). Thirteen (37%) studies were 
conducted in Europe, 16 (46%) in North America/Australia, and 6 (17%) in Asia/Africa 
(Table 1). Eight (23%) studies included comparison parents. The majority of studies 
(85%) included different cancer types. We observed large variations in study design, 
sample size, treatment phase, age at diagnosis, and follow-up time after diagnosis. 
Twenty-six (74%) studies reported on employment, 20 (57%) on income, 21 (60%) on 
financial situation, and 20 (57%) addressed financial assistance (Table 2). 
Impact of childhood cancer on parents´ socio-economic situation 
Employment 
A high prevalence of disruptions in parental employment including job quitting, job 
loss, unemployment, changes in work hours or extended leaves was reported. Most 
studies found more profound work disruptions among mothers compared to fathers. 
Twelve studies reported that mothers were more likely to quit work or to be 
unemployed after the child´s diagnosis24,25,28,30,31,35-38,44,46,49. Only one study from 
Indonesia showed higher work loss among fathers55. However, two studies from 
Australia49 and the UK36 observed that mothers were less likely to reduce work hours 
compared to fathers. Most work disruptions occurred shortly after diagnosis and 
attenuated within one year24,29,31,50. However, studies from Sweden28 and 
Switzerland35 identified higher unemployment among mothers even many years after 
diagnosis. Diagnosis of haematological cancer35,38,45, younger age of child at 
diagnosis38,43, lower maternal education28,35, and having more children28,31,35 were 
identified as the main characteristics associated with employment disruptions. 
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Income 
The majority of studies on income reported substantial income loss after the 
child´s diagnosis26,28,31,36,38-40,44,47,49-55,58. The proportion of parents reporting income 
loss and the extent of these losses varied largely. Two studies from Norway25 and 
Finland24 found no effects on income and one study from New Zealand52 found more 
parents reporting income gain than loss. Evidence related to gender differences is 
limited with two studies showing similar effects in mothers and fathers25,31, and one 
study each reporting higher income loss in mothers53 or fathers36. A population-based 
study from Sweden26,28 indicated that maternal income reductions persisted until six 
years after diagnosis compared to three years among fathers. Findings from 
longitudinal studies suggest that income losses are most pronounced in the first 
months after diagnosis24,31,39,40, but may persist into early survivorship26,28. Lower 
income at diagnosis28,40,44,47, younger age of child at diagnosis25,28,38, and diagnosis of 
leukaemia25,50 were consistently associated with income loss. 
Financial situation 
Parents´ financial situation ZDVDIIHFWHGE\WKHFKLOG¶VGLDJQRVLVacross all studies. 
The extent of the impact varied largely from 18% of parents reporting a great financial 
burden in Sweden32 to 83% in Kenya58. Two thirds of parents reported debts due to 
the child´s disease in studies from Asia and Africa53,55,58 and two of these studies 
additionally reported that parents withheld treatment due to financial reasons55,58. Also 
in the US, a study showed that 15% of families fell below the poverty level due to 
cancer-related financial strains44. Findings from three longitudinal studies24,39,40 
suggest that the impact on the financial situation peaks about six months after 
diagnosis and one study from the US reports that it persisted until 2.6 years after 
diagnosis39. The main characteristics associated with adverse consequences for 
parents´ financial situation were rural residency or greater distance to 
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hospital37,42,45,49,51,53, lower socio-economic position34,40,47,49,54, and single 
parenthood36,49. 
Financial assistance 
The different types and extent of financial assistance across studies precluded an 
overall synthesis. Only one Australian study emphasised that families received no 
assistance for most cancer-related expenses51. Two US studies reported that >50% 
of parents used individual fundraising as a financial coping strategy44,47. In Sweden, 
parents of children with cancer were more likely to rely on sickness or childcare 
benefits than comparison parents26,27. Sick leave was more often used by mothers 
than fathers26,27,31,36. Findings from longitudinal studies suggest that the uptake of such 
benefits is highest in the first months after diagnosis24,26,27,31,38 and decreases in early 
survivorship26,27,30,31,38. Non-governmental assistance appeared to be more often 
received by families with higher expenses or rural residency51, whereas the uptake of 
social security benefits was mainly associated with parents´ education, income, and 
cohabitation status26,27. 
Study quality 
The average quality rating was 5.0 (Supplementary table 1). Quality ratings were 
higher for studies reporting on income (mean=5.2) than for studies on employment 
(mean=4.7), financial situation (mean=4.6), and financial assistance (mean=4.7). We 
identified no conclusive patterns in the reported findings according to study quality. 
Quality ratings were higher for European studies (mean=6.5) compared to studies 
from North America/Australia (mean=4.3), and Asia/Africa (mean=4.0).  
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Discussion 
Our systematic review of 35 articles indicates that having a child with cancer may 
have a considerable impact on the parents´ socio-economic situation supporting 
conclusions from earlier reviews10,17. We found a high prevalence of disruptions in 
parental employment, particularly among mothers. The associated income losses 
contributed to families´ perceived financial burden. Socio-economic consequences 
were most pronounced shortly after diagnosis, however, persisted into early 
survivorship for certain groups of parents. We identified families with lower socio-
economic position, parents of children diagnosed with haematological cancers and 
diagnosed at younger age to be at particular risk for adverse socio-economic 
consequences. 
Disruptions in parents´ socio-economic situation varied largely by geographical 
region. Differences in regional labour market and economic circumstances, social 
welfare systems including health care services, and the extent of psycho-social 
support provided may account for this finding. A Swiss study estimated that parents 
need on average 240 working days for caretaking during the child´s treatment59. 
Consequently, parental work disruptions are likely and the social welfare system plays 
a crucial role in facilitating taking care for a diseased child while maintaining 
employment. Such systems are widely established in the Nordic countries which may 
result in a more modest impact compared to countries with less extensive welfare 
systems25. More pronounced employment disruptions among mothers may be 
explained by traditional parenting roles typically accrediting mothers the role of the 
child´s primary caregiver18. Mothers could profit from more flexible work arrangements 
such as home office or temporary reductions that support staying in the workforce 
while taking care for a diseased child28. Prolonged work absences may be problematic 
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for families´ future financial stability as the competitiveness in the labour market may 
be compromised due to lack of skill development or lost job opportunities. Indeed, a 
multi-national study concluded that mothers may experience career penalties even for 
short absence periods such as after childbirth60. However, an alternative explanation 
for prolonged changes may arise from altered priorities related to family life following 
the cancer experience12. From a political or legislative point of view, policy makers and 
employers play a crucial role in providing the opportunity for a successful combination 
of work and parenting responsibilities, particularly if the child is suffering from a severe 
disease such as cancer. 
The identification of parents at risk for adverse socio-economic consequences is 
essential to develop tailored support strategies along the cancer trajectory. Our review 
revealed that families with lower socio-economic position are particularly affected by 
the child´s disease. An explanation may be that parents with lower education are more 
often engaged in less flexible working arrangements with limited options to care for 
the diseased child while maintaining employment25,28. These families may also have 
less resources to cope with the cancer experience such as for organizing childcare or 
a smaller social support network61. The families´ socio-economic position may 
therefore further deteriorate and predispose all family members at risk for adverse 
health outcomes as outlined in the literature related to health inequalities62. Parents of 
children with haematological cancers and younger age at diagnosis are more likely to 
experience adverse socio-economic consequences. Haematological cancers 
anticipate an intense treatment protocol guided by chemotherapy with a long treatment 
duration (up to 2.5 years for acute lymphoblastic leukaemia)63. Moreover, regardless 
of any health condition, younger children require more parental care what more 
strongly interferes with the parents´ professional life64. 
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Study limitations 
A limitation refers to the large variations in outcome definition and methodological 
approaches across studies which limited between-study comparisons. Our findings 
mainly apply to high-income countries as studies from middle- or low-income countries 
are underrepresented. However, a family´s socio-economic situation may be of higher 
concern and public health relevance in such countries in regard to treatment access 
and health outcomes. Another limitation refers the self-reported information in many 
studies. This may have resulted in biased responses caused by social desirability with 
parents tending to present a more favourable image65. Finally, the explanatory power 
of the NOS for appraising study quality is limited as sample size is not considered21. 
This aspect is critical to identify characteristics associated with parents´ socio-
economic situation as smaller studies may be underpowered. 
However, the comprehensive literature search enabled the inclusion of studies 
from various countries with different socio-economic contexts. The search terms used 
ensured that a broad range of socio-economic consequences that parents of children 
with cancer may experience are captured. A major strength of our review refers to the 
scientifically rigorous methodological approach with searching relevant databases, 
performing an extensive hand search, and updating our search to include recent 
articles. Study selection and quality appraisal were performed independently by two 
researchers. 
Clinical implications 
Family poverty has been described as a negative prognostic indicator in paediatric 
oncology40. In 2015, standards for psycho-social care of children with cancer were 
published66 including a recommendation for assessing family financial hardship67. A 
follow-up study from the US outlined that while most paediatric oncology programs 
could implement some of these standards, lack of monetary resources precludes a 
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comprehensive implementation68 and only half of paediatric oncologists and 
psychosocial leaders agreed that their psychosocial care is state of the art69. However, 
a recent study from the US evaluating the feasibility of poverty screening in paediatric 
oncology revealed promising results by assessing household material hardship with a 
short screening tool in routine care70. From a global perspective, further efforts are 
needed to develop, implement and systematically evaluate cost- and time-effective 
screening tools for family financial hardship. Ideally, such screening tools lead to 
referral to targeted financial counselling and supportive services according the 
families´ risk profile67. This is of particular relevance as our review revealed that a 
majority of parents received financial assistance. Increasing the awareness of existing 
support services and guidance in navigating through potential administrative barriers 
may reduce the parents´ burden in the life-threatening context of having a child with 
cancer. 
In conclusion, parents experience a broad range of adverse socio-economic 
consequences following the child´s cancer diagnosis. Further effort is needed to 
systematically identify families at risk of financial hardship and to implement 
appropriate support services along the cancer trajectory to prevent future social 
inequities and adverse family outcomes5,71-73. 
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Table 1. Characteristics of included studies 
First author(year) Country Sample size Comparison group Cancer type Age at dx (years)Á Treatment phase Study design/data collection 
Follow-up time 
(years)Á 
Study 
quality 
Europe 
Lahteenmaki(2004)24 Finland T1:26 families 46 comparison families 
parents from day 
care centres mixed median=5 patients 
Longitudinal survey 
T1:3 months after dx 
T2:12 months after dx 
T1-T2 6 
Syse(2011)25 Norway 
3263 parents 
1227908 comparison 
parents 
general population mixed 
0-4:43% 
5-9:21% 
10-20:36% 
survivors/patients/ 
deceased Cohort;registry-based 
0-4 years:34% 
>5 years:67% 9 
Hiyoshi(2018)§,26 
Sweden 3626 parents 34874 comparison parents general population mixed median=7 
survivors/patients, 
deceased 
Cohort;registry-based; 
longitudinal follow-up 
Annually to 7 years 
after dx 9 Hjelmstedt(2017)
 §,27
 
Norberg(2016)§,28 
Hoven(2017)§,29 
Sweden T1:277 parents - mixed mean=8 
survivors/patients/ 
deceased 
Longitudinal survey 
T1:1 week after dx 
T2:2 months after dx 
T3:4 months after dx 
T4:1 week after treatment/6 
months after SCT 
T5:3 months after treatment/9 
months after SCT/death 
T6:1 year after treatment/18 
months after SCT/death 
T7:5 years after 
treatment/SCT/death 
T2-T6 
4 Wikman(2016)§,30 survivors/deceased T6-T7 
Hoven(2013)§,31 survivors/patients/ deceased T1-T6 
Hoven(2013)32 Sweden 551 families - CNS tumour mean=10 survivors Cross-sectional;survey mean=16 years 5 
Enskar(2011)33 Sweden 320 parents - mixed 0-18 survivors/patients Cross-sectional;survey in treatment:46% 
after treatment:54% 5 
Mader(2017)§,34 
Switzerland 
383 families 
769 comparison families general population mixed mean=3 survivors Cross-sectional;survey mean=9 years 
8 
Mader(2016)§,35 394 families 3341 comparison parents 7 
Eiser(2006)36 United Kingdom 145 families - mixed 0-20 survivors/patients Cross-sectional;survey 3-36 months after dx 5 
North America and Australia 
Tsimicalis(2012)37 Canada 99 parents - mixed mean=8 patients Cost-of-illness;diary 2-4 months after dx 4 
Limburg(2008)38 Canada 111 families - mixed 
0-4:40% 
5-9:13% 
10-20:39% 
survivors/deceased Cross-sectional;survey mean=4 years 4 
Bilodeau(2018)§,39 United States T3:52 families - mixed median=6 survivors Longitudinal survey T1:30 days after dx T3 5 
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Bona(2016)§,40 T1:99 families median=9 patients T2:6 months after dx T3:>1 year after treatment T1-T2 
Zamora(2016)41 United States 366 families - mixed 0-25 survivors/patients Cross-sectional;survey 
<1 year:44% 
1-3 years:48% 
4-5 years:8% 
5 
Warner(2014)42 United States 254 families - mixed mean=7 survivors/patients Cross-sectional;survey mean=2 years 5 
Lau(2014)43 United States T1:159 families - ALL 2-5:54% 5-10:46% patients 
Longitudinal survey 
T1:1 month after dx 
T2:6 months after dx 
T3:12 months after dx 
T1-T3 5 
Bona(2014)44 United States 71 families - mixed mean=10 patients Cross-sectional;survey mean=2 years 3 
Fluchel(2014)45 United States 354 families - mixed mean=7 patients Cross-sectional;survey mean=2 years 5 
Murphy(2008)46 United States 40 parents 20 comparison fathers 
fathers from local 
schools n.r. n.r. n.r. Cross-sectional;survey >4 months after dx 3 
Dussel(2011)47 United States Australia 230 families - mixed n.r. deceased Cross-sectional;survey/interview 
mean=4 years after 
death 4 
Monterosso(2009)48 Australia 69 families - mixed mean=7 deceased Cross-sectional;survey/interview 6-36 months after death 3 
Heath(2006)49 Australia 56 families parents of children 
with diabetes mixed n.r. survivors/patients Cross-sectional;survey >12 months after dx 4 
Goodenough(2004)50 Australia 104 families - mixed mean=7 survivors/patients Record review mean=2 years 4 
Cohn(2003)51 Australia 100 families - mixed mean=6 survivors/patients Cross-sectional;survey mean=3 years 4 
Dockerty(2003)52 New Zealand 237 families - mixed 0-14 survivors/patients/ deceased Cross-sectional;survey 
<1 year:8% 
1-2 years:59% 
>2 years:33% 
5 
Asia and Africa 
Sneha(2017)53 India 70 families - ALL;AML 0-18 patients Cross-sectional;survey/interview >3 months after dx 3 
Ghatak(2016)54 India 50 families - ALL mean=6 patients Cost-of-illness;diary 1 month after dx 4 
Mostert(2008)55 Indonesia 51 families - ALL 2-16 survivors/patients Cross-sectional;survey/interview in treatment:94% 
after treatment:6% 5 
Okada(2014)56 Japan 62 mothers - mixed mean=5 survivors Cross-sectional;survey mean=4 years 3 
Aung(2012)57 Singapore 79 families - mixed 
<5:51% 
5-10:25% 
10-20:24% 
survivors/patients Cross-sectional;survey >6 months after dx 5 
Njuguna(2015)58 Kenya 75 families - mixed 0-14 survivors/patients Cross-sectional;survey/interview 
at dx:5% 
in treatment:82% 
after treatment:13% 
4 
ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; CNS, central nervous system; dx, diagnosis; n.r., not reported; SCT, stem cell transplantation; T, time point. 
The term families is used if the family was addressed as a unit. 
ÁMean or median if reported. 
§Articles based on the same original study/data from the respective country. 
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Table 2. Impact of childhood cancer on parents´ socio-economic situation 
First author(year) Country Socio-economic consequences Differences mothers/fathers Temporal patterns Associations 
Employment 
Europe 
Lahteenmaki(2004)§,24 Finland 
Mothers less often employed and fewer work 
hours than comparison mothers 
Similar employment and work hours of fathers 
and comparison fathers 
Fewer mothers employed during entire follow-
up 
Mothers worked fewer hours during entire 
follow-up 
Employment from 3 to 12 months after dx: 
Mothers: 54%(T1),65%(T2) 
Fathers: 95%(T1),93%(T2) 
- 
Syse(2011)25 Norway Similar employment as comparison parents 
>90% employed at end of follow-up Fewer mothers employed (87%vs.93%) No association with time since dx 
Employment 
Bone tumour(mothers) 
Child death(mothers) 
Lower education(mothers) 
Being married(fathers) 
Norberg(2016)§,28 Sweden 
Mothers more often unemployed than 
comparison mothers 
Similar employment of fathers and comparison 
fathers 
Mothers more often unemployed during entire 
follow-up 
Higher unemployment in mothers than 
comparison mothers up to 5 years after dx 
No change in employment of fathers 
Unemployment(mothers) 
Lower education 
Higher population density 
Children at home 
Hoven(2017)§,29 Sweden Majority reported work restrictions after dx More mothers reported work restrictions during 
entire follow-up 
Work restrictions decreased from 2 months 
after dx to 1 year after treatment: 
75%(T2),67%(T3),49%(T4),34%(T5),16%(T6) 
Work restrictionsÁ 
Post-traumatic stress 
Child´s symptom burden 
Wikman(2016)§,30 Sweden Majority employed during entire follow-up 
Fewer mothers of survivors employed 
(92%vs.96%) 
Similar employment in bereaved parents 
(91%vs.90%) 
Employment 1 and 5 years after treatment: 
Parents of survivors: 86%(T6),94%(T7) 
Bereaved parents :86%(T6),91%(T7) 
- 
Hoven(2013)§,31 Sweden Majority stopped/reduced work after dx Fewer mothers employed during entire follow-
up 
Work stop/reduction from 2 months after dx to 
1 year after treatment: 
Mothers: 83%(T2),52%(T4),47% (T5),28%(T6) 
Fathers: 60%(T2),41%(T4),21%(T5),17%(T6) 
Unemployment 
Shorter treatment(T4) 
Poor prognosis(T6) 
VLEOLQJV7 
Mader(2016)35 Switzerland 
Mothers more often unemployed than 
comparison mothers (29%vs.22%) 
Fathers more often full-time employed than 
comparison fathers (93%vs.87%) 
More mothers unemployed (29%vs.3%) 
Fewer mothers full-time employed (9%vs.93%) No association with time since dx 
Unemployment 
Lower education(mothers) 
>2 children(mothers) 
Lymphoma(mothers) 
Relapse(fathers) 
Eiser(2006)36 United Kingdom 
35% of mothers and 2% of fathers quit job 
29% of mothers and 37% of fathers reduced 
work hours 
71% of mothers and 27% of fathers took 
unpaid leave 
More mothers quit job (35%vs.2%) 
Less mothers reduced work hours 
(29%vs.37%) 
- - 
North America and Australia 
Tsimicalis(2012)37 Canada 
65% of mothers and 63% of fathers reported 
work loss 
>50% of mothers and 5% of fathers reported 
unemployment 
More mothers unemployed (>50%vs.5%) - - 
Limburg(2008)38 Canada 
64% of mothers and 16% of fathers took 
extended leave/quit job 
Majority returned to same job within 1 year 
More mothers left work (64%vs.16%) 
More mothers quit job (13%vs.11%) - 
Work leaveÁ 
Leukaemia 
Younger age at dx 
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Bona(2016)§,40 United States 
56% reported work disruptions 
15% quit/lost job 
37% took leave/reduced work hours 
- 
6 months after dx: 
56% reported work disruptions(T2) 
15% quit/lost job(T2) 
37% took leave/reduced work hours(T2) 
- 
Zamora(2016)41 United States 
36% quit/changed job 
PLVVHGZRUNGD\VLQILUVWPRQWKVRI
treatment 
- - - 
Warner(2014)42 United States One third quit/changed job - No association with time since dx - 
Lau(2014)§,43 United States 
46% lost job (vs.9% in census) 
18% increased work hours 
68% decreased work hours 
51% declined work opportunities 
- 
From 1 to 12 months after dx: 
Increase work hours: 
7%(T1),13%(T2),18%(T3) 
Decrease work hours: 
42%(T1),61%(T2),68%(T3) 
Decline work opportunities: 
20%(T1),39%(T2),51%(T3) 
Increase work hours 
Treatment 
Decline work opportunities 
Lower income 
Younger age at dx 
Treatment 
Bona(2014)44 United States 94% reported work disruptions 42% one or both parents quit job More mothers quit job (33%vs.6%) - - 
Fluchel(2014)45 United States 
UHSRUWHGTXLWWLQJFKDQJLQJMRERI
parent 
Mean of 14 monthly missed work days after dx 
- - 
Missed work days 
Rural residency 
Longer travel time to centre 
Quit job 
AML 
Murphy(2008)46 United States 
40% of mothers and 100% of fathers employed 
Fathers worked more hours than comparison 
fathers (48vs.43) 
Fewer mothers employed (40%vs.100%) 
Mothers worked fewer hours (29vs.48) - - 
Dussel(2011)47 United States Australia 
35% and 49% in US and Australia quit job 
52% and 58% in US and Australia reduced 
work hours 
More mothers reduced work hours in US 
(39%vs.14%) and Australia (24%vs.23%) - - 
Monterosso(2009)48 Australia 56% full-time home carer during palliative care - - - 
Heath(2006)49 Australia 77% reported work disruptions More mothers quit job Less mothers reduced work - - 
Goodenough(2004)50 Australia 58% reported work disruptions 2% increased work hours 
More mothers reported work disruptions 
(81%vs.35%) Most work disruptions in first 6 weeks after dx - 
Cohn(2003)51 Australia 
49% reported work disruptions 
33% quit job/reduced work hours 
16% increased work hours 
- - 
Increase work hoursÁ 
Rural residency 
Younger age 
Asia and Africa 
Sneha(2017)53 India 38% increased work hours - - - 
Ghatak(2016)54 India 
34% of fathers lost job 
16% closed shop/business 
22% took unpaid leave 
- - - 
Mostert(2008)55 Indonesia 8% of mothers and 29% of fathers lost job Fewer mothers lost job (8%vs.29%) - - 
Okada(2014)56 Japan 31% quit job 38% took extended leave - - 
Quit job/extended leaveÁ 
Lower work motivation 
Less social support 
Income 
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Europe 
Lahteenmaki(2004)§,24 Finland Family income similar to comparison families - 
Income loss high during first months after dx 
Income remains similar from 3 to 12 months 
after dx(T1-T2) 
- 
Syse(2011)25 Norway Minor effects on income 
Non-VLJQLILFDQWUHGXFWLRQLQPRWKHUV¶
income 
1RUHGXFWLRQLQIDWKHUV¶LQFRPH 
Maternal income reductions more pronounced 
\HDUVDIWHUG[ 
Income reduction 
CNS tumour, germ cell 
tumour, 
leukaemia(mothers) 
Younger age at dx(mothers) 
Higher education(mothers) 
Not being married(fathers) 
Mader(2017)34 Switzerland Lower household income than comparison parents - - - 
Hiyoshi(2018)§,26 Sweden Income decreased after dx and thereafter 
remained lower than comparison parents Longer income reductions in mothers after dx 
Income reductions most pronounced around dx 
Income of mothers reduced until 7 years after 
dx 
Income of fathers reduced until 2 years after dx 
Income loss(mothers) 
Lower education 
Child death 
Parent-couple household 
Norberg(2016)§,28 Sweden Income decreased after dx and thereafter 
remained lower than comparison parents Longer income reductions in mothers after dx 
Income reductions most pronounced around dx 
Income of mothers reduced until 7 years after 
dx 
Income of fathers reduced until 2 years after dx 
Income loss 
Lower income at 
dx(mothers) 
Lower education 
Younger age 
Unemployment at 
dx(mothers) 
Intermediate-/densely-
populated area(mothers) 
Not born in 
Sweden(mothers) 
Children at home(mothers) 
Younger age at dx 
Partnership(fathers) 
Hoven(2013)§,31 Sweden Income reduced during treatment and similar 1 year after treatment 
Income reductions similar during entire follow-
up 
Income reduced during treatment until 3 
months after treatment(T2-T5), similar 1 year 
after treatment(T6) 
Lower income 
Male child 
Eiser(2006)36 United Kingdom 
43% reported financial impact due to income 
loss  
Financial impact more often due to fathers´ 
than mothers´ income loss (18%vs.12%) - - 
North America and Australia 
Limburg(2008)38 Canada Decrease in income from salary - Income from salary increased with time since dx 
Lower income from salaryÁ 
Younger age at dx 
Bilodeau(2018)§,39 United States Income loss of 22% (36% lost >40% of annual income) - 
Income loss of 22% until >1 year after 
treatment(T3) - 
Bona(2016)§,40 United States Income loss of 7% (25% lost >40% of annual income) - Income loss of 7% until 6 months after dx(T2) 
Income loss 
Lower income 
Bona(2014)44 United States Income loss of 20% (14% lost >40% of annual income) - - 
Income lossÁ 
Lower income 
Dussel(2011)47 United States Australia 60% reported income loss of >10% - - 
Income lossÁ 
Lower income  
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Heath(2006)49 Australia Great income loss in first 12 months after dx - - - 
Goodenough(2004)50 Australia Family income loss of 53% - - Income loss
Á
 
Leukaemia 
Cohn(2003)51 Australia One third reported income loss - - - 
Dockerty(2003)52 New Zealand 43% reported income increase 23% reported income loss - - - 
Asia and Africa 
Sneha(2017)53 India Majority reported income loss More mothers reported income loss - - 
Ghatak(2016)54 India 72% reported income loss - - - 
Mostert(2008)55 Indonesia 69% reported income loss - - - 
Njuguna(2015)58 Kenya 66% reported income loss - - - 
Financial situation 
Europe 
Lahteenmaki(2004)§,24 Finland >40% reported significant financial impact - Financial impact similar 3 and 12 months after dx: 42%(T1),43%(T2) - 
Mader(2017)34 Switzerland Higher risk-of-poverty than comparison parents - No association with time since dx 
Risk-of-poverty 
Lower education 
Language 
Hoven(2013)32 Sweden 18% reported significant financial burden - No association with time since dx 
Financial burden 
Poorer health of child 
Unmet care needs 
Enskar(2011)33 Sweden Majority reported financial situation became 
worse 
Similar reporting that financial situation 
became worse 
Financial situation worse on compared to off 
treatment (mothers: 86%vs.66%; fathers: 
87%vs.63%) 
Financial burden 
Active treatment 
Eiser(2006)36 United Kingdom 
55% reported cancer-related expenses 
68% reported money worries - 
Cancer-related expenses highest in first 6 
months after dx 
ExpensesÁ 
Active treatment 
Relapse 
Money worriesÁ 
Single parenthood 
North America and Australia 
Tsimicalis(2012)37 Canada 37% of annual income for cancer-related 
expenses - - 
ExpensesÁ 
Rural residency 
Higher income 
Bilodeau(2018)§,39 United States 44% reported great financial hardship 33% reported material hardship - 
Material hardship increased from dx to >1 year 
after treatment: 15%(T1),33%(T2),33%(T3) - 
Bona(2016)§,40 United States 
56% reported moderate/great financial 
hardship 
29% reported material hardship 
- 
Material hardship increased from dx to 6 
months after dx: 20%(T1),29%(T2) 
Material hardship 
Lower income 
Warner(2014)42 United States Mean financial burden 67/100 - No association with time since dx 
Financial burden 
More hospitalizations 
Quitting/changing job 
Rural residency 
Bona(2014)44 United States 
28% reported great financial hardship 
15% fell below poverty level 
40% reported debts 
- - - 
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Fluchel(2014)45 United States Mean financial burden 66/100 - - 
Financial burdenÁ 
Rural residency 
Longer travel time to centre 
Dussel(2011)47 United States Australia 
24% in US and 39% in Australia reported great 
financial hardship 
16% in US and 22% in Australia dropped 
below poverty level 
- - 
Financial hardshipÁ 
Lower education(US) 
Younger age(US) 
Poverty 
Income loss 
Monterosso(2009)48 Australia 41% reported high financial burden - - - 
Heath(2006)49 Australia 
74% reported great/moderate financial 
hardship 
Majority reported cancer-related expenses 
- - 
Financial hardshipÁ 
Single parenthood 
Lower income 
Greater distance to hospital 
Cohn(2003)51 Australia UHSRUWHGW\SHVRIFDQFHU-related 
expenses - - 
ExpensesÁ 
Rural residency 
Dockerty(2003)52 New Zealand 
Mean financial burden 48/100 
13% of family income for cancer-related 
expenses 
- - 
Financial burdenÁ 
Longer time in hospital 
Asia and Africa 
Sneha(2017)53 India Majority reported financial burden 68% reported debts - - 
Financial burdenÁ 
Rural residency 
Ghatak(2016)54 India Cancer-related expenses exceeded family income - - 
Expenses 
Lower socio-economic 
position 
Mostert(2008)55 Indonesia 
78% reported financial difficulties 
65% reported debts 
18% withhold treatment due to finances 
- - - 
Aung(2012)57 Singapore Financial burden second highest family impact - - Financial burden
Á 
Work leave 
Njuguna(2015)58 Kenya 
83% reported great financial burden 
64% reported debts 
28% withhold treatment due to finances 
- - - 
Financial assistance 
Europe 
Lahteenmaki(2004)§,24 Finland Maternity/child care leave similar to 
comparison families Maternity/child care leave similar 
Maternity/child care leave increased from 3 to 
12 months after dx: 
Mothers: 0%(T1),6%(T2) 
Fathers: 0%(T1),7%(T2) 
- 
Hiyoshi(2018)§,26 Sweden 
More sickness and childcare benefits than 
comparison parents 
Less often unemployment benefits than 
comparison parents 
More mothers received sickness, childcare or 
unemployment benefits 
Benefit uptake most pronounced around dx 
More sickness and childcare benefits than 
comparison parents up to few years after 
diagnosis 
Sickness benefits 
Child death 
Lower education(mothers) 
Childcare 
benefits(mothers) 
Single parenthood 
Unemployment benefits 
Parent-couple 
household(fathers) 
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Higher education(fathers) 
Lower education(mothers) 
Hjelmstedt(2017)§,27 Sweden 
More sickness benefits than comparison 
parents (at dx: mothers 42%vs.17%, fathers 
33%vs.9%) 
More mothers received sickness benefits (at 
dx: 42%vs.33%) 
Benefit uptake most pronounced around dx 
More sickness benefits than comparison 
parents up to 4 years after dx for mothers and 
3 years for fathers 
Sickness benefit days 
Born in Sweden 
Parent-couple household 
Higher income 
Higher education 
Child death 
Younger age(fathers) 
Wikman(2016)§,30 Sweden One fifth reported sick leave during follow-up 
Sick leave similar in mothers and fathers of 
survivors (20%vs.18%) or bereaved mothers 
and fathers (14%vs.20%) 
Sick leave 1 and 5 years after treatment: 
Parents of survivors: 16%(T6),19%(T7) 
Bereaved parents: 38%(T6),17%(T7) 
- 
Hoven(2013)§,31 Sweden Highest proportion of sick leave during treatment 
More mothers on sick leave during entire 
follow-up and for longer periods after dx 
Sick leave increased from 1 week to 2 months 
after dx and decreased to 1 year after 
treatment: 
Mothers: 
5%(T1),80%(T2),80%(T3),57%(T4),45%(T5),2
3%(T6) 
Fathers: 
0%(T1),53%(T2),50%(T3),27%(T4),13%(T5),5
%(T6) 
Sick leave 
Higher treatment intensity 
Eiser(2006)36 United Kingdom 
31% of mothers and 14% of fathers on sick 
leave 
47% of mothers and 61% of fathers on 
compassionate leave 
Majority received Disability Living Allowance or 
other assistance 
More mothers on sick leave (31%vs.14%) 
Fewer mothers on compassionate leave 
(48%vs.61%) 
- - 
North America and Australia 
Limburg(2008)38 Canada 44% received employment insurance, social 
and/or other assistance at diagnosis - 
Employment insurance, social and/or other 
financial assistance decreased with time since 
dx (44% at dx vs. 20% at survey) 
Financial assistanceÁ 
Younger age at dx 
Bona(2016)§,40 United States 34% taking leave received pay 53% took unpaid family/medical leave - - - 
Bona(2014)44 United States 51% used fundraising - - - 
Dussel(2011)47 United States Australia 
52% in US and 33% in Australia used 
fundraising - - 
FundraisingÁ 
Poverty(US) 
Monterosso(2009)48 Australia 
4% took paid leave 
20% received disability support pension 
41% received disability/carer allowance 
- - - 
Heath(2006)49 Australia 
50% took sick leave/vacation 
Large variation in assistance from 
governmental and non-governmental sources 
- - - 
Goodenough(2004)50 Australia 
68% received assistance for living expenses 
52% received hospital-specific assistance 
46% received assistance for 
accommodation/travel  
- - 
Financial assistanceÁ 
Income loss 
Cohn(2003)51 Australia 35% took annual/sick leave - - Financial assistanceÁ 
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dx, diagnosis; AML, acute myeloid leukemia. 
Statistically significant in adjusted analyses. 
ÁStatistically significant in unadjusted analyses. 
§Longitudinal study design. 
No assistance for most cancer-related 
expenses 
Rural residency 
Higher expenses 
Dockerty(2003)52 New Zealand 89% received assistance from governmental 
and non-governmental sources - - - 
Asia and Africa 
Ghatak(2016)54 India 
12% took paid leave 
78% received assistance from governmental 
and non-governmental sources  
Fewer mothers took paid leave (2%vs.10%) - - 
Mostert(2008)55 Indonesia 61% requested assistance from family - - - 
Okada(2014)56 Japan 6% took family care leave 6% took sick/child care leave - - - 
Aung(2012)57 Singapore 61% received assistance - - - 
Njuguna(2015)58 Kenya 
47% received assistance from friends, 41% 
from relatives, 36% from community, 29% from 
grandparents 
- - - 
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Figure 1. Flow chart of inclusion and exclusion of identified articles 
 
